Zobrazeno 1 - 10
of 2 746
pro vyhledávání: '"Dimovski A"'
Autor:
Dzekova-Vidimliski P, Eftimovska-Otovikj N, Nikolov I G, Selim Gj, Rambabova-Bushljetik I, Pushevski V, Karanfilovski V, Matevska-Geshovska N, Dimovski A
Publikováno v:
Balkan Journal of Medical Genetics, Vol 26, Iss 2, Pp 27-34 (2024)
The polymorphism of the angiotensin-converting enzyme (ACE) gene and interleukin-1 beta (IL-1b) gene could be associated with resistance in the treatment of anemia in dialysis patients with recombinant human erythropoietin (rHuEPO). The aim of the st
Externí odkaz:
https://doaj.org/article/aab6c2e7dda24fa78d69f54610ed5873
Publikováno v:
Balkan Journal of Medical Genetics, Vol 26, Iss 2, Pp 35-40 (2024)
Clopidogrel, is a standard treatment in the prevention of major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD). Clopidogrel response is highly variable, mainly due to the presence of polymorphisms in the genes inv
Externí odkaz:
https://doaj.org/article/da5b9cbc1fc540559f18a73a83586699
Publikováno v:
Acta Pharmaceutica, Vol 73, Iss 3, Pp 363-384 (2023)
The advancements in proteomics have provided a better understanding of the functionality of apolipoproteins and lipoprotein-associated proteins, with the HDL lipoprotein fraction being the most studied. The focus of this study was to evaluate the HDL
Externí odkaz:
https://doaj.org/article/ac5e79b0514541b68efb42071adda702
Autor:
VAVLUKIS ANA, VAVLUKIS MARIJA, DIMOVSKI ALEKSANDAR, PETRUSHEVSKA GORDANA, EFTIMOV ALEKSANDAR, DOMAZETOVSKA SASHKA, MLADENOVSKA KRISTINA
Publikováno v:
Acta Pharmaceutica, Vol 72, Iss 2, Pp 303-315 (2022)
Statins have shown anti-inflammatory pleiotropic effects in subjects with/at risk of cardiovascular disease. The aim of this study was to evaluate the inflammatory/immunomodulatory properties of rosuvastatin in subjects at low-to-moderate cardiovascu
Externí odkaz:
https://doaj.org/article/4c016631a3ad4511a8c11e6f0a6ff19b
Autor:
Popova-Labachevska M, Panovska-Stavridis I, Eftimov A, Kapedanovska Nestorovska A, Cevreska L, Ivanovski M, Ridova N, Trajkova S, Dimovski AJ
Publikováno v:
Balkan Journal of Medical Genetics, Vol 22, Iss 2, Pp 31-36 (2019)
The identification of the JAK2V617F mutation in several distinct myeloproliferative neoplasms (MPNs) raised the question how one single mutation incites expression of at least three different clinical phenotypes, i.e., polycythemia vera (PV), essenti
Externí odkaz:
https://doaj.org/article/2c38d23238de4936b1da294fbf181777
Autor:
Staninova-Stojovska M, Matevska-Geskovska N, Panovski M, Angelovska B, Mitrevski N, Ristevski M, Jovanovic R, Dimovski AJ
Publikováno v:
Balkan Journal of Medical Genetics, Vol 22, Iss 2, Pp 5-16 (2019)
Hereditary factors are assumed to play a role in ~35.0-45.0% of all colorectal cancers (CRCs) with about 5.0-10.0% associated with high penetrant disease-causing mutations in genes correlated to hereditary polyposis (HP) or hereditary non polyposis s
Externí odkaz:
https://doaj.org/article/ed75dbeefda447baaeecd21f23dbd0f0
Autor:
Kapedanovska-Nestorovska A, Dimovski AJ, Sterjev Z, Matevska Geskovska N, Suturkova L, Ugurov P, Mitrev Z, Rosalia R
Publikováno v:
Pharmacogenomics and Personalized Medicine, Vol Volume 12, Pp 287-295 (2019)
Aleksandra Kapedanovska-Nestorovska,1 Aleksandar J Dimovski,1,2 Zoran Sterjev,1 Nadica Matevska Geskovska,1 Ljubica Suturkova,1 Petar Ugurov,3 Zan Mitrev,4 Rodney Rosalia5 1Center for Biomolecular and Pharmaceutical Analysis, Faculty of Pharmacy, Uni
Externí odkaz:
https://doaj.org/article/096c2c2bd82f4ce994f33f46fae0263e
Autor:
Kapedanovska Nestorovska Aleksandra, Jakjovski Krume, Naumovska Zorica, Sterjev Zoran, Geskovska Nadica Matevska, Mladenovska Kristina, Suturkova Ljubica, Dimovski Aleksandar
Publikováno v:
Acta Pharmaceutica, Vol 69, Iss 3, Pp 399-412 (2019)
The relative contribution of CYP2C9 allelic variants to the pharmacokinetics (PK) of ibuprofen (IBP) enantiomers has been studied extensively, but the potential clinical benefit of pharmacogenetically guided IBP treatment is not evident yet. The role
Externí odkaz:
https://doaj.org/article/f2e49c5c14c346c89871f395269d2d7d
Autor:
Matevska-Geshkovska N, Staninova-Stojovska M, Kapedanovska-Nestorovska A, Petrushevska-Angelovska N, Panovski M, Grozdanovska B, Mitreski N, Dimovski A
Publikováno v:
Pharmacogenomics and Personalized Medicine, Vol Volume 11, Pp 193-203 (2018)
Nadica Matevska-Geshkovska,1 Marija Staninova-Stojovska,1 Aleksandra Kapedanovska-Nestorovska,1 Natalija Petrushevska-Angelovska,2 Milco Panovski,3 Biljana Grozdanovska,2 Nenad Mitreski,2 Aleksandar Dimovski1 1Center for Biomolecular Pharmaceutical A
Externí odkaz:
https://doaj.org/article/485acc70be4d4b418ce352dee63c7615
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 10, Pp 339-347 (2018)
Zorica Naumovska,1 Aleksandra K Nestorovska,1 Aleksandra Grozdanova,1 Kristina Hristova,2 Aleksandar Dimovski,1 Ljubica Suturkova,1 Zoran Sterjev1 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, SS “Cyril and Methodius”, Skopje, Rep
Externí odkaz:
https://doaj.org/article/71705794ea1a4bbcb90b5423aa01489b